Navin Fluorine Reports Record FY26 Driven by Capacity Expansion and Margin Growth

Navin Fluorine International Ltd (NFIL) has reported a strong finish to fiscal year 2025-26, marking its sixth consecutive quarter of revenue and profitability growth. The company's full-year Net Operating Revenue reached INR 3,314 crore, a substantial 41% increase year-on-year. Operating EBITDA more than doubled to INR 1,082 crore, with margins expanding significantly to 32.6%.

Capacity Expansion Fuels Performance

A key driver for this performance was the successful commissioning of the Anhydrous Hydrogen Fluoride (AHF) plant, with commercial supplies now underway. This backward integration initiative is crucial for NFIL's future product development and cost competitiveness. The company also saw an improvement in its net working capital cycle, reducing it from 90 days in FY25 to 74 days in FY26, pointing to enhanced operational efficiency.

Strategic Investments Pay Off

These results reflect the company's strategic investments over recent years in significant capacity expansions. Projects included the AHF plant for backward integration, a major expansion of R32 refrigerant capacity, and dedicated facilities for its Contract Development and Manufacturing Organisation (CDMO) business. These expansions were designed to capitalize on growth in high-value fluorochemicals, meet demand for eco-friendly refrigerants, and serve pharmaceutical and agrochemical clients.

Looking Ahead: FY27 Targets and Margin Focus

With the AHF plant operational, NFIL is well-positioned to leverage its backward integration for higher-margin products. Further expansions, including R32 capacity, are slated to commence in fiscal year 2027. The company has set an ambitious target of $100 million in revenue for its CDMO business in FY27, indicating strong client commitments. Management expressed confidence in maintaining EBITDA margins around 30% (+/- 1-2%) for FY27, supported by an optimized product mix and operational efficiency.

Navigating Risks and Challenges

Despite the strong performance, management pointed to potential risks. Raw material inflation and geopolitical sensitivities affecting energy prices and supply chains remain watchpoints. Execution challenges were noted, particularly in customer qualification for Project Nectar, which is progressing slower than initially targeted. Additionally, regional logistics issues in the Middle East led to an estimated loss of INR 15-16 crore in shipments during Q4 FY26.

Competitive Landscape

NFIL operates in a competitive market alongside players like Aarti Industries and SRF Ltd. Gujarat Fluorochemicals is a direct competitor, also undertaking significant capital expenditure, with plans for INR 1,600 crore in FY26-27 for fluoropolymers and battery materials.

Key Metrics to Track

Investors will be closely watching NFIL's progress on several fronts: the achievement of its $100 million CDMO revenue target for FY27, the commissioning of the R32 capacity expansion by Q3 FY27, and the maintenance of EBITDA margins near the 30% target. Progress on the Dahej MPP debottlenecking and Chemours project completion by the end of June/early July will also be key. Management's ability to manage raw material inflation and pass costs effectively, alongside the outlook for the structurally strong but currently slow Agchem sector, will be critical.